Literature DB >> 15170712

Early ostial saphenous vein graft stenosis associated with the use of Symmetry sutureless aortic proximal anastomosis device: successful percutaneous revascularization.

Sharon L Cline1, Anuradha Guduvalli, Vijay G Kalaria.   

Abstract

A recent advance in technology permits the creation of sutureless proximal aortic anastomosis during coronary artery bypass graft surgery. This new tool has significant potential benefit by minimizing aortic manipulation with subsequent reduction in neuroembolization. Implantation of a nitinol-based proximal aortic connector (Symmetry) has a potential to elicit intimal hyperplastic reaction analogous to restenosis after coronary stent placement. We report cases of early vein graft stenosis in association with the use of the Symmetry device. Three patients suffered from severe ostial stenosis within 6 months of bypass surgery with symptomatic presentation. Of these three patients, two underwent successful percutaneous revascularization. Fluoroscopic star-shaped appearance of the metallic Symmetry allows device recognition during angiography. We review current data regarding graft patency with the use of Symmetry device and discuss technical issues to address specific problems during percutaneous revascularization. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15170712     DOI: 10.1002/ccd.20048

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Mid-term follow up of patients using the St. Jude Medical Aortic Connector System for proximal vein graft in CABG.

Authors:  Cheol Hyun Chung; Jae Won Lee; Joon Kyu Kang; Hyun Song; Suk Jung Choo; Meong Gun Song
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

2.  Establishment of an animal model of vascular restenosis with bilateral carotid artery grafting.

Authors:  Ruixiong Li; Bin Lan; Tianxiang Zhu; Yanlong Yang; Muting Wang; Chensheng Ma; Shu Chen
Journal:  Med Sci Monit       Date:  2014-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.